G Ramu
About
In The Last Decade
G Ramu
139 papers receiving 751 citations
Peers
Comparison fields: 5 of 92
- Infectious Diseases 624
- Epidemiology 401
- Surgery 256
- Immunology 98
- Molecular Biology 72
Countries citing papers authored by G Ramu
This map shows the geographic impact of G Ramu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Ramu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Ramu more than expected).
Fields of papers citing papers by G Ramu
This network shows the impact of papers produced by G Ramu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Ramu. The network helps show where G Ramu may publish in the future.
Co-authorship network of co-authors of G Ramu
This figure shows the co-authorship network connecting the top 25 collaborators of G Ramu. A scholar is included among the top collaborators of G Ramu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Ramu. G Ramu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Assay and stability studies of cobicistat and atazanavir sulphate in combined dosage form by RP-UPLC method | 1 |
| 2 | Validation of stability indicating rp-hplc method for the assay of ibrutinib in pharmaceutical dosage form | 6 |
| 3 | DEVELOPMENT OF LIQUID CHROMATOGRAPHIC AND VISIBLE SPECTROPHOTOMETRIC METHODS FOR THE ESTIMATION OF CLOBAZAM IN TABLET DOSAGE FORMS | 1 |
| 4 | A new LCMS/MS method for estimation of Bupropion and its metabolite in human plasma | 1 |
| 5 | A new RP-HPLC method development for the estimation of an antithrombocythemic agent anagrelide in pure and pharmaceutical formulations | 1 |
| 6 | Tablet disintegrant activities of new starch from immature pepino fruits | 3 |
| 7 | 10 | |
| 8 | Evaluation of Abelmoschus starch as tablet disintegrant | 0 |
| 9 | Relapses in paucibacillary patients after treatment with three short-term regimens containing rifampin. | 8 |
| 10 | 7 | |
| 11 | Cardiovascular Involvemant in Leprosy Patients | 1 |
| 12 | Serum iron and total iron binding capacity in leprosy patients. | 3 |
| 13 | An open trial with clofazimine in the management of recurrent lepra reaction using thalidomide as a control drug. | 10 |
| 14 | Social reaction to leprosy in a rural population in Chingleput District (Tamil Nadu). | 11 |
| 15 | Toxic reactions to parent sulphone. Report of four cases. | 1 |
| 16 | Arthritis in lepromatous leprosy. Clinical features and biochemical findings. | 6 |
| 17 | Smallpox Vaccination and Acute Exacerbation of Leprosy. | 1 |
| 18 | Treatment of Lepra Reaction and some of its Special Manifestations. | 1 |
| 19 | Reactive States in Lepromatous Leprosy. A Study from the Clinical and Bacteriological Aspects. | 4 |
| 20 | A preliminary trial of chloroquine diphosphate in lepra reaction. | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.